FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37396860> ?p ?o ?g. }

• Q37396860 description "article científic" @default.
• Q37396860 description "article scientifique" @default.
• Q37396860 description "articolo scientifico" @default.
• Q37396860 description "artigo científico" @default.
• Q37396860 description "artículu científicu espublizáu en 2013" @default.
• Q37396860 description "bilimsel makale" @default.
• Q37396860 description "scientific article published on 14 August 2013" @default.
• Q37396860 description "vedecký článok" @default.
• Q37396860 description "vetenskaplig artikel" @default.
• Q37396860 description "videnskabelig artikel" @default.
• Q37396860 description "vědecký článek" @default.
• Q37396860 description "wetenschappelijk artikel" @default.
• Q37396860 description "wissenschaftlicher Artikel" @default.
• Q37396860 description "наукова стаття, опублікована в серпні 2013" @default.
• Q37396860 description "научни чланак" @default.
• Q37396860 description "مقالة علمية نشرت في 14 أغسطس 2013" @default.
• Q37396860 name "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 name "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 name "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 type Item @default.
• Q37396860 label "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 label "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 label "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 prefLabel "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 prefLabel "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 prefLabel "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 P1433 Q37396860-72D43CEC-9B5D-4756-9556-FEC286EE3F03 @default.
• Q37396860 P1476 Q37396860-9D6877B8-ED27-4E95-A68E-3AD6DFEE72B0 @default.
• Q37396860 P2093 Q37396860-4A0AAAFA-0C7A-4C05-8C9D-7ACBC9145274 @default.
• Q37396860 P2093 Q37396860-5D6FC034-AE7F-4859-A489-16B67984A29E @default.
• Q37396860 P2093 Q37396860-D172AABF-EB3E-49C7-9E78-D4E21B23CFA2 @default.
• Q37396860 P2860 Q37396860-02B023FE-166E-416C-8314-5E713E5B967F @default.
• Q37396860 P2860 Q37396860-05C191B6-379D-47F9-B2B6-B34817B13E9F @default.
• Q37396860 P2860 Q37396860-0BAA3B15-F402-4190-8ACB-CFC516DDE559 @default.
• Q37396860 P2860 Q37396860-0DC2E0E1-8CB1-49F2-8F53-97613F497643 @default.
• Q37396860 P2860 Q37396860-0DD88D53-F2B5-4C9D-A59A-ECA6E42B4EBF @default.
• Q37396860 P2860 Q37396860-13A7BB2F-760E-43AB-8781-1EDB9CD37FDE @default.
• Q37396860 P2860 Q37396860-156F5A61-3DFF-452D-AFE4-A79BB0AE420E @default.
• Q37396860 P2860 Q37396860-17657E18-E7F6-4B5C-AFED-3366E0B5773B @default.
• Q37396860 P2860 Q37396860-279191D2-1667-4C8A-A1A6-B845A6EF085F @default.
• Q37396860 P2860 Q37396860-2C2BBFED-9F81-4BFE-AAEC-97C076B5B746 @default.
• Q37396860 P2860 Q37396860-2FBC0E60-5718-458A-B3BA-4EAE8240ECA4 @default.
• Q37396860 P2860 Q37396860-31214C6A-4FDB-4383-9902-33A41ECAA414 @default.
• Q37396860 P2860 Q37396860-31FCB3AE-AF99-4A37-B0E4-937B8DC213D8 @default.
• Q37396860 P2860 Q37396860-42F312F2-520A-4D50-97F2-9065B3001D10 @default.
• Q37396860 P2860 Q37396860-45C7B5D2-E4A9-477D-BCB9-4DD96E1D463F @default.
• Q37396860 P2860 Q37396860-4B31B95D-BACE-4099-B94B-716C4689FA26 @default.
• Q37396860 P2860 Q37396860-55B9CB91-3EC4-4CCF-A5F4-FA12E0F61723 @default.
• Q37396860 P2860 Q37396860-56FC73CB-3422-4E1B-AA19-491DE7049B41 @default.
• Q37396860 P2860 Q37396860-5F9E0FC2-9412-4798-95FB-A79030B30CCF @default.
• Q37396860 P2860 Q37396860-6AF9DBB9-0EEC-40CA-AC9F-0CC002501781 @default.
• Q37396860 P2860 Q37396860-6E9A05B8-E1E3-4883-A5F7-B02C159125F7 @default.
• Q37396860 P2860 Q37396860-712DA9BD-2852-4DB0-9DE9-9A8B10ABBF56 @default.
• Q37396860 P2860 Q37396860-7B3AFCE3-5AA8-47B5-A18B-39CCBB75E55B @default.
• Q37396860 P2860 Q37396860-7BE89A7A-57AF-4B8F-B509-1E104FE64D51 @default.
• Q37396860 P2860 Q37396860-7CD5DB5D-A34A-4064-AE3B-C949174A8941 @default.
• Q37396860 P2860 Q37396860-885F8606-7159-4B77-BCEA-D8C566712368 @default.
• Q37396860 P2860 Q37396860-8BB046E8-7EA9-41D6-A850-C94358A234B4 @default.
• Q37396860 P2860 Q37396860-9963AA4F-BA63-47C9-86FC-7F6A3B5BC7BF @default.
• Q37396860 P2860 Q37396860-9B288756-120F-4E79-84B0-BAD079AFBE53 @default.
• Q37396860 P2860 Q37396860-A718712F-1FDC-445D-9B26-DC84EE01F480 @default.
• Q37396860 P2860 Q37396860-AF6A8C5A-DD5B-4CCD-92B9-904E7ECA73DF @default.
• Q37396860 P2860 Q37396860-B21822DE-F6A8-464F-AE24-21873E7B8258 @default.
• Q37396860 P2860 Q37396860-B7EDA164-C922-49FB-B809-3125C50DB717 @default.
• Q37396860 P2860 Q37396860-BB99C386-8A41-4A56-88DF-306A4AD83B41 @default.
• Q37396860 P2860 Q37396860-BFAC1459-3541-49DE-96D1-2F06C502D1C4 @default.
• Q37396860 P2860 Q37396860-C04FF27C-A9E0-4216-A082-377F4E743CA5 @default.
• Q37396860 P2860 Q37396860-C6F13FB0-2409-493E-BB2A-0FDCAF0F1687 @default.
• Q37396860 P2860 Q37396860-C9D5C11D-12D1-432A-8C1D-49C3F1140918 @default.
• Q37396860 P2860 Q37396860-D77EE521-1B7A-4794-9899-8AD30E29F663 @default.
• Q37396860 P2860 Q37396860-D7C1C59A-C8D0-485F-9FDF-F35D2E1327B3 @default.
• Q37396860 P2860 Q37396860-DDA609E0-8CD5-4DF1-84AA-C5E3DCDF6721 @default.
• Q37396860 P2860 Q37396860-E1EF97CB-26C0-41EC-91B8-E8A4C2E346FA @default.
• Q37396860 P2860 Q37396860-EAACD9E8-7C9B-4187-9099-DDF9BDADE555 @default.
• Q37396860 P2860 Q37396860-F547F28F-6E71-43A7-A7BF-C12EB729A1AD @default.
• Q37396860 P2860 Q37396860-FBE6B975-754A-48B8-A82E-5862F160CFDA @default.
• Q37396860 P2860 Q37396860-FE3C8263-9212-4335-8FDA-A9B27964350E @default.
• Q37396860 P304 Q37396860-8295770E-4ACB-485A-BE39-BCCBD7054EC1 @default.
• Q37396860 P31 Q37396860-0A756FAB-5845-46B9-B2C0-C27574C70585 @default.
• Q37396860 P356 Q37396860-B8751692-CE7E-4B65-B9B1-DF8D37EAF015 @default.
• Q37396860 P478 Q37396860-5B0244B0-BDEB-464A-88F8-408B184E8D35 @default.
• Q37396860 P577 Q37396860-2489D589-F69E-47A7-B7CA-0B5AFF81A615 @default.
• Q37396860 P5875 Q37396860-5174367C-1507-424C-852E-8E84FA3FFE82 @default.
• Q37396860 P698 Q37396860-3CB4FDE8-5865-4847-8F08-5FEEFC93A191 @default.
• Q37396860 P932 Q37396860-60DECAA8-7199-4BCF-9685-CE8680B84C16 @default.
• Q37396860 P356 J.NEUROPHARM.2013.05.031 @default.
• Q37396860 P698 23954676 @default.
• Q37396860 P1433 Q15332439 @default.
• Q37396860 P1476 "Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity" @default.
• Q37396860 P2093 "Ming Li" @default.
• Q37396860 P2093 "Rongyin Qin" @default.
• Q37396860 P2093 "Yingzhu Chen" @default.
• Q37396860 P2860 Q28270767 @default.
• Q37396860 P2860 Q30365347 @default.
• Q37396860 P2860 Q30390855 @default.
• Q37396860 P2860 Q30443699 @default.
• Q37396860 P2860 Q30455893 @default.
• Q37396860 P2860 Q30458533 @default.
• Q37396860 P2860 Q34313092 @default.
• Q37396860 P2860 Q36074345 @default.

• next